Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PTPI |
---|---|---|
09:32 ET | 6546 | 1.4289 |
09:34 ET | 1300 | 1.45 |
09:36 ET | 1560 | 1.434 |
09:38 ET | 600 | 1.4433 |
09:39 ET | 4440 | 1.4201 |
09:41 ET | 6500 | 1.44 |
09:43 ET | 2891 | 1.43 |
09:45 ET | 1400 | 1.46 |
09:48 ET | 2455 | 1.4403 |
09:50 ET | 2907 | 1.4314 |
09:52 ET | 100 | 1.4393 |
09:54 ET | 550 | 1.43 |
09:56 ET | 308 | 1.44 |
09:57 ET | 1050 | 1.45 |
09:59 ET | 2524 | 1.451 |
10:01 ET | 275 | 1.455 |
10:03 ET | 5644 | 1.46 |
10:06 ET | 300 | 1.46 |
10:08 ET | 250 | 1.4599 |
10:10 ET | 1204 | 1.46 |
10:12 ET | 185 | 1.4594 |
10:14 ET | 2200 | 1.47 |
10:15 ET | 2818 | 1.45 |
10:21 ET | 688 | 1.47 |
10:24 ET | 10678 | 1.47 |
10:26 ET | 3574 | 1.45 |
10:28 ET | 150 | 1.46 |
10:30 ET | 2950 | 1.45 |
10:33 ET | 742 | 1.45 |
10:35 ET | 6100 | 1.451 |
10:37 ET | 6000 | 1.4682 |
10:39 ET | 2600 | 1.45 |
10:42 ET | 700 | 1.46 |
10:44 ET | 1039 | 1.46 |
10:48 ET | 200 | 1.46 |
10:51 ET | 3500 | 1.4501 |
10:55 ET | 100 | 1.455 |
10:57 ET | 300 | 1.45 |
11:00 ET | 830 | 1.46 |
11:02 ET | 500 | 1.452 |
11:04 ET | 100 | 1.4501 |
11:08 ET | 700 | 1.4555 |
11:09 ET | 1900 | 1.458 |
11:18 ET | 150 | 1.455 |
11:20 ET | 733 | 1.45 |
11:22 ET | 448 | 1.45 |
11:29 ET | 270 | 1.46 |
11:36 ET | 1300 | 1.4602 |
11:38 ET | 4931 | 1.4601 |
11:44 ET | 700 | 1.4601 |
11:45 ET | 600 | 1.46 |
11:49 ET | 100 | 1.4601 |
12:00 ET | 199 | 1.465 |
12:14 ET | 2264 | 1.46 |
12:20 ET | 100 | 1.46 |
12:25 ET | 12293 | 1.46 |
12:27 ET | 1100 | 1.4601 |
12:30 ET | 100 | 1.465 |
12:32 ET | 7906 | 1.48 |
12:34 ET | 348 | 1.49 |
12:38 ET | 100 | 1.48 |
12:41 ET | 1109 | 1.48 |
12:45 ET | 350 | 1.4797 |
12:48 ET | 700 | 1.47 |
12:50 ET | 4801 | 1.48 |
12:57 ET | 3474 | 1.482 |
01:01 ET | 400 | 1.4899 |
01:08 ET | 1975 | 1.495 |
01:10 ET | 300 | 1.4901 |
01:12 ET | 14955 | 1.4998 |
01:14 ET | 3262 | 1.4985 |
01:15 ET | 1475 | 1.4968 |
01:17 ET | 500 | 1.495 |
01:19 ET | 10603 | 1.48 |
01:21 ET | 100 | 1.49 |
01:24 ET | 1550 | 1.4901 |
01:26 ET | 4049 | 1.49 |
01:28 ET | 125 | 1.495 |
01:30 ET | 14781 | 1.51 |
01:32 ET | 4636 | 1.51 |
01:33 ET | 14809 | 1.51 |
01:35 ET | 3760 | 1.5099 |
01:39 ET | 600 | 1.51 |
01:42 ET | 200 | 1.5 |
01:44 ET | 100 | 1.5039 |
01:48 ET | 100 | 1.505 |
01:50 ET | 600 | 1.5008 |
01:51 ET | 1000 | 1.5097 |
01:53 ET | 500 | 1.5001 |
01:55 ET | 1400 | 1.4901 |
01:57 ET | 500 | 1.4924 |
02:00 ET | 165 | 1.49 |
02:02 ET | 1000 | 1.495 |
02:04 ET | 1090 | 1.5 |
02:06 ET | 7035 | 1.4706 |
02:08 ET | 2105 | 1.4722 |
02:09 ET | 1462 | 1.498 |
02:11 ET | 485 | 1.495 |
02:13 ET | 300 | 1.49 |
02:15 ET | 600 | 1.49 |
02:20 ET | 1100 | 1.47 |
02:26 ET | 5229 | 1.465 |
02:27 ET | 1710 | 1.46 |
02:31 ET | 1700 | 1.4739 |
02:33 ET | 200 | 1.48 |
02:36 ET | 239 | 1.4899 |
02:38 ET | 2582 | 1.4601 |
02:40 ET | 800 | 1.4799 |
02:42 ET | 1000 | 1.47 |
02:44 ET | 1000 | 1.47 |
02:45 ET | 2800 | 1.46 |
02:47 ET | 150 | 1.4601 |
02:49 ET | 1000 | 1.47 |
02:51 ET | 1100 | 1.46 |
02:54 ET | 1697 | 1.462 |
02:58 ET | 10000 | 1.4666 |
03:00 ET | 811 | 1.4899 |
03:02 ET | 155 | 1.4899 |
03:03 ET | 1100 | 1.4803 |
03:07 ET | 2300 | 1.49 |
03:09 ET | 500 | 1.4875 |
03:12 ET | 3600 | 1.49 |
03:14 ET | 900 | 1.49 |
03:16 ET | 8735 | 1.49 |
03:18 ET | 100 | 1.49 |
03:20 ET | 4000 | 1.4899 |
03:25 ET | 123 | 1.49 |
03:32 ET | 15584 | 1.4901 |
03:36 ET | 3400 | 1.49 |
03:39 ET | 646 | 1.49 |
03:45 ET | 195 | 1.48 |
03:52 ET | 10205 | 1.475 |
03:56 ET | 11244 | 1.48 |
03:59 ET | 1356 | 1.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Petros Pharmaceuticals Inc | 3.3M | -0.2x | --- |
TC BioPharm Ltd | 1.8M | 0.0x | --- |
Stemcell Holdings Inc | 1.6M | 750.0x | --- |
Pulmatrix Inc | 6.4M | -0.4x | --- |
Kineta Inc | 5.8M | -0.4x | --- |
Globeimmune Inc | 10.0 | 0.0x | --- |
Petros Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on men’s health therapeutics with a full range of commercial capabilities including sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It commercializes therapeutics for men's health issues, such as endothelial dysfunction, psychosexual and psychosocial ailments, hormone health, and substance-use disorders. It also commercializes and develops Stendra, a PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also markets its own line of ED products in the form of vacuum erection device products through its subsidiaries, Timm Medical and PTV. In addition to ED products, it has a global license (the Hybrid License) to develop and commercialize H100, a novel and patented topical formulation candidate for the treatment of acute Peyronies disease.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3M |
---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 2.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-6.05 |
Book Value | $8.03 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -181.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.